Scarica l'app Stockscreener
92.21
1.26%
-1.18
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$93.39
Aprire:
$92.875
Volume 24 ore:
257.95K
Relative Volume:
0.99
Capitalizzazione di mercato:
$2.11B
Reddito:
$256.28M
Utile/perdita netta:
$62.40M
Rapporto P/E:
33.98
EPS:
2.7139
Flusso di cassa netto:
$79.12M
1 W Prestazione:
-0.14%
1M Prestazione:
-5.24%
6M Prestazione:
+8.57%
1 anno Prestazione:
+13.83%
Intervallo 1D:
$90.95
$93.99
Intervallo di 1 settimana:
$90.87
$94.87
Portata 52W:
$79.00
$118.01
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Nome
Lemaitre Vascular Inc
Settore
Industria
Telefono
781-221-2266
Indirizzo
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
92.21 | 2.10B | 256.28M | 62.40M | 79.12M | 2.7139 |
ISRG
Intuitive Surgical Inc
|
402.18 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
141.61 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
64.14 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.42 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
186.29 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-06 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Iniziato | Wells Fargo | Equal Weight |
| 2024-10-15 | Iniziato | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Ripresa | Lake Street | Buy |
| 2024-05-31 | Ripresa | ROTH MKM | Buy |
| 2024-04-26 | Aggiornamento | Stifel | Hold → Buy |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-06 | Iniziato | Oppenheimer | Outperform |
| 2023-08-03 | Downgrade | Jefferies | Buy → Hold |
| 2023-05-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Iniziato | Jefferies | Buy |
| 2021-02-12 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Aggiornamento | Sidoti | Neutral → Buy |
| 2019-10-24 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Aggiornamento | Lake Street | Hold → Buy |
| 2019-10-14 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Reiterato | Barrington Research | Outperform |
| 2019-07-25 | Aggiornamento | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Ripresa | ROTH Capital | Buy |
| 2018-04-26 | Downgrade | Stifel | Buy → Hold |
| 2018-04-26 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Downgrade | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Iniziato | First Analysis Sec | Overweight |
| 2017-02-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Downgrade | Sidoti | Buy → Neutral |
| 2016-07-28 | Reiterato | Barrington Research | Outperform |
| 2016-02-25 | Reiterato | Barrington Research | Outperform |
Mostra tutto
Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie
Kennedy Capital Management LLC Has $20.11 Million Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular Shareholders Back Directors, Pay and Auditor - TipRanks
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
LeMaitre Vascular declares $0.25 dividend - MSN
LeMaitre Vascular (NASDAQ:LMAT) Shares Cross Above 200 Day Moving AverageTime to Sell? - MarketBeat
LMAT Q1 2026 Earnings: EPS Slightly Beats Estimates, Shares RiseEarnings Deceleration Risk - newsline.com
LeMaitre Vascular Inc. (LMAT) Q1 2026 Earnings: EPS Slightly Beats Estimates Amid Modest Stock Uptick - newsline.com
Jefferies recaps meetings with Healthcare Services companies - Investing.com
LMAT Q1 2026 Earnings: EPS Beats Estimates by 0.86%, Shares Inch HigherAnnual Report - newsline.com
LeMaitre Vascular (NASDAQ: LMAT) director gets dividend equivalent awards - Stock Titan
LeMaitre Vascular (LMAT) director receives new dividend equivalent rights grants - Stock Titan
LeMaitre (NASDAQ: LMAT) director gets dividend equivalent right awards - Stock Titan
[Form 4] LEMAITRE VASCULAR INC Insider Trading Activity - Stock Titan
LeMaitre Vascular (LMAT) director receives dividend equivalent rights awards - Stock Titan
LeMaitre Vascular (NASDAQ: LMAT) CFO receives new dividend rights awards - Stock Titan
LeMaitre Vascular (LMAT) director receives dividend equivalent right grants - Stock Titan
LeMaitre Vascular (LMAT) awards dividend equivalent rights to executive - Stock Titan
LeMaitre Vascular (NASDAQ: LMAT) CEO gifts 11,974 shares, receives dividend rights - Stock Titan
Price-Driven Insight from (LMAT) for Rule-Based Strategy - Stock Traders Daily
LeMaitre Vascular (LMAT) holders approve directors, say-on-pay and 2026 auditor - Stock Titan
LeMaitre Vascular (LMAT) Gains Ground as Stock Approaches Key ResistanceUndervalued Stocks - newsline.com
LMAT Maintained by Barrington Research -- Price Target Steady at $120 - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Receives Outperform Rating from Barrington Research - MarketBeat
Q3 2025 LeMaitre Vascular Inc Earnings Call Transcript - GuruFocus
LMAT Q1 2026 Earnings: Modest EPS Beat Amid Steady PerformanceDiluted EPS Report - newsline.com
How The LeMaitre Vascular (LMAT) Story Is Shifting As Analysts Lift Fair Value Targets - Yahoo Finance
LMAT Q1 2026 Earnings: EPS Beats Estimates by Narrow Margin, Stock Declines SlightlyBook Value Growth - newsline.com
AlphaQuest LLC Grows Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular Inc. (LMAT) Holds Steady Near $98 as Traders Await CatalystTrend Continuation Trade - The Legal Advocate
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
(LMAT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Thrivent Financial for Lutherans Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Winners And Losers Of Q1: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
LeMaitre Vascular to join two major healthcare investor conferences in June - Pluang
LeMaitre to Participate at Upcoming Investor Conferences in June - The Manila Times
LeMaitre schedules June talks at Jefferies and Goldman healthcare events - Stock Titan
GSA Capital Partners LLP Has $1.72 Million Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular (LMAT) Unchanged at $101.43 — Range-Bound Trading 2026-05-20Wedge Breakout - The Legal Advocate
LeMaitre Vascular (LMAT) Q1 2026 Results Top Views on Strong RevenueEarnings Expansion Phase - newsline.com
Three Healthcare Stocks Facing Potential Headwinds in 2026 - IndexBox
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $105 to $124 - Moomoo
Wakefield Asset Management LLLP Buys New Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
5 Insightful Analyst Questions From LeMaitre’s Q1 Earnings Call - Yahoo Finance
LeMaitre Vascular stock (US52567J1079): Q1 beat and raised 2026 guidance - AD HOC NEWS
[SCHEDULE 13G/A] LEMAITRE VASCULAR INC Amended Passive Investment Disclosure - Stock Titan
LeMaitre Vascular Senior Vice President of Operations Trent Kamke Sells 44% Of Holding - Moomoo
(LMAT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Why LeMaitre Vascular (LMAT) Is Down 10.9% After Raising 2026 Guidance And Boosting Dividends - simplywall.st
Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $120 - 富途牛牛
Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround - Yahoo Finance
Lemaitre Vascular Inc Azioni (LMAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lemaitre Vascular Inc Azioni (LMAT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| LeMaitre George W | Chairman and CEO |
May 07 '26 |
Sale |
107.64 |
18,600 |
2,002,013 |
1,457,900 |
| Kamke Trent G | Senior V. P., Operations |
May 08 '26 |
Sale |
107.00 |
2,928 |
313,287 |
3,749 |
| Ross Bridget A | Director |
May 07 '26 |
Option Exercise |
48.15 |
5,044 |
242,882 |
8,986 |
| Ross Bridget A | Director |
May 07 '26 |
Sale |
111.10 |
5,044 |
560,366 |
3,942 |
| Jasinski Lawrence J | Director |
May 07 '26 |
Option Exercise |
65.92 |
2,858 |
188,412 |
8,657 |
| Jasinski Lawrence J | Director |
May 07 '26 |
Sale |
110.00 |
3,943 |
433,730 |
4,714 |
5.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):